Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 1995

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

dehydroepiandrosterone

All Listed Sponsors

collaborator

Northwestern University

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004665 - Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter